Clinical Trial Update: A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating SOT101 in combination with pembrolizumab in selected advanced solid tumors was terminated; results have been posted. The trial included…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Colorectal Cancer
• Cutaneous Squamous Cell Carcinoma
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• SOT101

Snippet

Sponsor: SOTIO Biotech AG | Conditions: Non-Small Cell Lung Cancer, Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-11-17